Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: Toxicol In Vitro. 2023 Feb 15;89:105568. doi: 10.1016/j.tiv.2023.105568

Figure 5:

Figure 5:

Overlap between PCB52 and 4-OH-PCB52 treatments. A. Genes considered to be altered in common between PCB52 and 4-OH-PCB52 treatments at day 3 post-treatment. Those genes altered by PCB52 were sorted according to log2fold change, largest to smallest. B. Genes altered in common between PCB52 and 4-OH-PCB52 across at least 2 of 3 time points.